The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
Been silence for months on the news front . Anyone got any predictions when we will see an update from the company about what they have been upto??
I have given up thinking the company are making positive moves behind the scenes until the day an announcement stating so comes forward.. I don’t understand how we have not been notified regarding submission , what it could mean I can’t even guess
Are we due an announcement stating they have submitted for p3 or will they likely hold out till the outcome ? Volume been building I noticed recently but no massive moves in price
strange but potentially encouraging announcement. the fact dividend has been mentioned makes me think its a sure thing otherwise why mention it for the first time in forever ... could it be another deal has been struck somewhere and they are giving back to the neglected shareholders now that the tax bill has been settled ? all wild speculation on my part but i live in hope with regent
When and where did they say that?
good move .. tax bill paid and can be forgotten. Endurance must obviously have some serious faith in venturex that price will go higher due to keeping a substantial holding in the game …
Could you please send a link to the announcement bignose ? Another step potentially in right direction
Thank you heimdel, yet again more interesting posts, the real unknown is what value interested parties would put on the potential of fortacin in the USA but that is information we will never know until a potential deal is announced I guess . Has anything happened to add time to fda process Italian? I haven’t seen anything so remain hopeful it can be smooth process
Announcements regarding licensees etc always seemed to say aim of taking place “ before or during phase 3 …” hopefully it’s smooth sailing to get through p2 then who knows … to a big pharma company it would be small change getting involved here with us and could be a gamble for them that pays off .
As much as I would love to agree with bothwell, we have been getting similar statements from announcements for a long long time with nothing coming to fruition
Sorry what do you mean bothwell?
Can you elaborate bothwell as to why you think that after recent statements from bignose and Italians ? A counter point would be interesting
I would like to ask you guys thoughts on potential of American market . The previous presentations the company have put out have shown the huge significance of the American market in comparison to eu etc . I assume due to pricing of drugs and ability to market /advertise . Even if the drug had low sales in eu at present time ( which I am not sure of) , could America be a catalyst to raise awareness around the world if it was used and rated highly ? I believe so , but interested to hear thoughts
The company obviously had communications with fda and knew the trial size requirements , I’m sure al the previous euro and us trials could be taken into account in some additional way also .maybe the pieces are falling into place
In regard to the DLI hopefully it’s a positive step , after reading the announcement it seems the 2 consultants are highly qualified ( Harvard and buck institute I think ) so would like to think they know what they are talking about .
read over it a few times.. hopefully this can be the catalyst to a rebound, the data sounds very good and it seems good work has been done in the background and will continue to be , whilst we were all debating and waiting. onwards and upwards
I don’t suppose anyone has any idea when we will hear some sort of update etc ?? At least venturex is holding up well
trying to look at the positives.... venturex is holding well and still awaiting news regarding FDA so it can't be ruled out that a good outcome may be achieved !!
I take it the company have no obligation to update the market by today then even though they had stated by end of June ? Really hopeful we can get a good update and turn the corner , would be great if trial has gone smoothly so far
Has fortacin ever had bad results in terms of the effect of it ? I can’t see why all of a sudden this would be the case so I’m quietly optimistic things could turn out ok here.
Venturex on the up again … name change coming … yet the price keeps dropping